SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-003907
Filing Date
2023-01-20
Accepted
2023-01-20 08:03:23
Documents
14
Period of Report
2023-01-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea171897-8k_180life.htm   iXBRL 8-K 46531
2 SEPARATION AND RELEASE AGREEMENT, DATED JANUARY 18, 2023, BY AND BETWEEN 180 LIF ea171897ex10-1_180life.htm EX-10.1 69115
  Complete submission text file 0001213900-23-003907.txt   358272

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20230118.xsd EX-101.SCH 3992
4 XBRL DEFINITION FILE atnf-20230118_def.xml EX-101.DEF 26629
5 XBRL LABEL FILE atnf-20230118_lab.xml EX-101.LAB 36680
6 XBRL PRESENTATION FILE atnf-20230118_pre.xml EX-101.PRE 25253
8 EXTRACTED XBRL INSTANCE DOCUMENT ea171897-8k_180life_htm.xml XML 5866
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 23538942
SIC: 2834 Pharmaceutical Preparations